Found: 6
Select item for more details and to access through your institution.
Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel.
- Published in:
- British Journal of Pharmacology, 1999, v. 127, n. 5, p. 1065, doi. 10.1038/sj.bjp.0702599
- By:
- Publication type:
- Article
UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.
- Published in:
- European Heart Journal, 2019, v. 40, n. 36, p. 3013, doi. 10.1093/eurheartj/ehz190
- By:
- Publication type:
- Article
The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design.
- Published in:
- Clinical Cardiology, 2019, v. 42, n. 12, p. 1147, doi. 10.1002/clc.23279
- By:
- Publication type:
- Article
Regulation of mammalian Shaker-related K<sup>+</sup> channels: evidence for non-conducting closed and non-conducting inactivated states.
- Published in:
- Journal of Physiology, 1998, v. 506, n. 2, p. 291, doi. 10.1111/j.1469-7793.1998.291bw.x
- By:
- Publication type:
- Article